פרדקסה 75
boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - קפסולות - dabigatran etexilate as mesilate 75 mg - dabigatran etexilate
פרדקסה 75
boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - קפסולות - dabigatran etexilate as mesilate 75 mg - dabigatran etexilate
וארגטף 100 מג
boehringer ingelheim israel ltd. - nintedanib as esilate - קפסולות רכות - nintedanib as esilate 100 mg
וארגטף 150 מג
boehringer ingelheim israel ltd. - nintedanib as esilate - קפסולות רכות - nintedanib as esilate 150 mg
האלבן
eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin - eribulin - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease. prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.
האלבן
eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin - eribulin - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease. prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.
האלבן
neopharm scientific ltd - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin
האלבן
eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin
לנווימה 10 מג
eisai israel ltd., israel - lenvatinib as mesilate - קפסולה קשיחה - lenvatinib as mesilate 10 mg - lenvatinib
לנווימה 4 מג
eisai israel ltd., israel - lenvatinib as mesilate - קפסולה קשיחה - lenvatinib as mesilate 4 mg - lenvatinib